{"id":639,"date":"2021-07-11T00:10:45","date_gmt":"2021-07-10T21:10:45","guid":{"rendered":"http:\/\/serdarcatav.com\/?page_id=639"},"modified":"2021-07-11T00:15:10","modified_gmt":"2021-07-10T21:15:10","slug":"kanser-agrilari","status":"publish","type":"page","link":"https:\/\/serdarcatav.com\/ru\/agrilarimiz\/kanser-agrilari\/","title":{"rendered":"Kanser A\u011fr\u0131lar\u0131"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"639\" class=\"elementor elementor-639\">\n\t\t\t\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-75ba645 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"75ba645\" data-element_type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;gradient&quot;}\">\n\t\t\t\t\t\t\t<div class=\"elementor-background-overlay\"><\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-8a763b4\" data-id=\"8a763b4\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-ed56182 elementor-widget elementor-widget-heading\" data-id=\"ed56182\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">Kanser A\u011fr\u0131lar\u0131\n<\/h1>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3f5470b elementor-icon-list--layout-inline elementor-align-center elementor-list-item-link-full_width elementor-widget elementor-widget-icon-list\" data-id=\"3f5470b\" data-element_type=\"widget\" data-widget_type=\"icon-list.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<ul class=\"elementor-icon-list-items elementor-inline-items\">\n\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item elementor-inline-item\">\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"http:\/\/serdarcatav.com\/\">\n\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<i aria-hidden=\"true\" class=\"icon icon-home\"><\/i>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Anasayfa<\/span>\n\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item elementor-inline-item\">\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"http:\/\/serdarcatav.com\/hastaliklar\/\">\n\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<i aria-hidden=\"true\" class=\"fas fa-chevron-right\"><\/i>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Hastal\u0131klar<\/span>\n\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item elementor-inline-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<i aria-hidden=\"true\" class=\"fas fa-chevron-right\"><\/i>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Kanser A\u011fr\u0131lar\u0131<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t<\/ul>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-f5095d6 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"f5095d6\" data-element_type=\"section\">\n\t\t\t\t\t\t\t<div class=\"elementor-background-overlay\"><\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-082c98f\" data-id=\"082c98f\" data-element_type=\"column\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-1c88e3c elementor-widget elementor-widget-heading\" data-id=\"1c88e3c\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Kanser A\u011fr\u0131lar\u0131\n<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-93e97d0 elementor-widget elementor-widget-text-editor\" data-id=\"93e97d0\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p>Her kanser hastas\u0131 ya\u015fad\u0131\u011f\u0131 a\u011fr\u0131y\u0131 farkl\u0131 derecelerde tarifler. Ger\u00e7ekten de ya\u015fan\u0131lan a\u011fr\u0131n\u0131n boyutu altta yatan kanser \u00e7e\u015fidine ve v\u00fccudun direncine ba\u011fl\u0131 olarak de\u011fi\u015fkenlik g\u00f6stermektedir.<br><b>Kanser A\u011fr\u0131s\u0131n\u0131n Temelde 3 Sebebi Vard\u0131r;<\/b><br><\/p>\n<ol style=\"\">\n<li style=\"\">% 75 ihtimalle kansere yol a\u00e7an t\u00fcm\u00f6r\u00fcn invazyonuna ba\u011fl\u0131 a\u011fr\u0131lar<\/li>\n<li style=\"\">% 20 oranla kanser tedavisinde radyoterapi ve kemoterapi tedavilerine ba\u011fl\u0131 a\u011fr\u0131lar<\/li>\n<li style=\"\">% 5 ise ba\u015fka nedenlerden yani kanserden tamamen farkl\u0131 k\u00f6kenli a\u011fr\u0131lar<\/li>\n<\/ol>\n<p><b>Kanser A\u011fr\u0131lar\u0131n\u0131n Lokalizasyonlar\u0131<\/b><br>Kemiklerde Tutulum: Kemik a\u011fr\u0131s\u0131 kanser kemiklere metastaz yapt\u0131ysa olu\u015fabilir. Akci\u011fer kanserlerinin % 20-30\u2019unda, meme ve prostat kanserlerinin ise % 50-70\u2019inde kemik a\u011fr\u0131s\u0131 \u015fikayetleri vard\u0131r. Kanser kemi\u011fe metastaz yapt\u0131ysa baz\u0131 hastalarda a\u011fr\u0131 hi\u00e7 g\u00f6r\u00fclmeyebilir. Fakat g\u00f6r\u00fclen a\u011fr\u0131lar da daha \u00e7ok geceleri ba\u015flayan ve egzersizle artan \u015fiddetli derecede a\u011fr\u0131lard\u0131r. Yans\u0131yan a\u011fr\u0131 olduysa durum daha karma\u015f\u0131kt\u0131r. \u00d6rne\u011fin bel a\u011fr\u0131s\u0131 bacakta hissedilebilir. E\u011fer t\u00fcmorden kaynakl\u0131 bir sinir bas\u0131s\u0131 a\u011fr\u0131s\u0131 varsa bat\u0131c\u0131 tarzda semptom verecektir.<br><br><b>Vertebral Tutulum:<\/b> Kanserin metastaz yapt\u0131\u011f\u0131 vertebral b\u00f6lgelere g\u00f6re oransal de\u011fi\u015fiklik g\u00f6stermektedir. \u00d6rne\u011fin olgular\u0131n % 65\u2019inde s\u0131rtta, % 20\u2019sinde bel ve le\u011fen kemi\u011finde, % 10\u2019u da boyun b\u00f6lgesinde kanser k\u00f6kenli a\u011fr\u0131lar hissediyor. Vertebral Tutulum oldu\u011funda a\u011fr\u0131n\u0131n tarz\u0131 da daima s\u0131zlayan ve lokalize edilebilen t\u00fcrden olmaktad\u0131r. Bazen a\u011fr\u0131, ayakta durmakla azalabilmekte ve oturmakla ya da bas\u0131 ile artabilmektedir.<br><br><b>Ba\u015f Tutulumu:<\/b> Kanser hastalar\u0131nda % 50 ihtimalle intrakranyal metastazlar ve t\u00fcm\u00f6rler vard\u0131r. Bunlar\u0131n yakla\u015f\u0131k yar\u0131s\u0131nda ba\u015f a\u011fr\u0131s\u0131 \u015fikayetleri vard\u0131r. Kanserle ve metastazla beraber g\u00f6rme bozukluklar\u0131, n\u00f6ropsikiyatrik hastal\u0131klar ve hemiparezi gibi durumlar da g\u00f6r\u00fclebilmektedir.<br><br><b>Kanserde A\u011fr\u0131 Y\u00f6netimi<br><\/b>Kanser a\u011fr\u0131lar\u0131nda d\u00fcnya sa\u011fl\u0131k \u00f6rg\u00fct\u00fc yakla\u015f\u0131k % 80 oranda ya\u015fanan \u00e7e\u015fitli a\u011fr\u0131lar\u0131n kontrol alt\u0131na al\u0131nabilece\u011fini s\u00f6ylemektedir. Bu sayede hastalar\u0131n da ya\u015fam kalitesi y\u00fckselecektir.<br>A\u011fr\u0131n\u0131n nedeni, tipi, yeri gibi durumlar ile a\u011fr\u0131n\u0131n ne zaman ba\u015flad\u0131\u011f\u0131 ve \u015fiddeti hakk\u0131nda derin bilgiler edinilmelidir. Hastan\u0131n ifadesi bu durumda son derece \u00f6nemlidir. Hasta \u201ca\u011fr\u0131m var\u201d diyorsa mutlaka etkin tedavi y\u00f6ntemleri ba\u015flanmal\u0131d\u0131r. D\u00fczenli ve s\u0131k aral\u0131klarla hasta kontrol edilmelidir. Verilen ila\u00e7lar yeterli gelmiyorsa doz art\u0131r\u0131m\u0131 ya da ila\u00e7 de\u011fi\u015fikli\u011fi yap\u0131lmal\u0131d\u0131r. Tedaviye \u00f6ncelikle parenteral ba\u015fland\u0131ysa daha sonra oral ya da transdermal y\u00f6ntemler tercih edilmelidir. Hasta yak\u0131nlar\u0131 da tedavi s\u00fcrecinde aktif olmal\u0131 ve hastaya a\u011fr\u0131lar\u0131n\u0131n tamamen ge\u00e7mese de hafifleyece\u011fini anlatmal\u0131d\u0131r. Hastan\u0131n hekim taraf\u0131ndan kontrollerinde say\u0131sal a\u011fr\u0131 \u00f6l\u00e7ek skalalar\u0131 taraf\u0131ndan objektif de\u011ferlendirilmesi \u00e7ok \u00f6nemlidir.<br><br><b>Kanserde A\u011fr\u0131 \u015eiddeti<br><\/b>Kanser a\u011fr\u0131lar\u0131n\u0131n tedavisinde temel mekanizma; a\u011fr\u0131 \u015fiddetinin belirlenmesi ve ard\u0131ndan kontrol alt\u0131na al\u0131nmas\u0131d\u0131r. Bunu da hastayla koordineli bir \u015fekilde ileti\u015fim kurarak sa\u011flayabiliriz. A\u011fr\u0131 hasta taraf\u0131ndan subjektif bir \u015fekilde anlat\u0131lsa da \u00e7e\u015fitli say\u0131sal, s\u00f6zel ve g\u00f6rsel skalalar\u0131 kullanarak a\u011fr\u0131n\u0131n \u015fiddetine g\u00f6re tedavi planlanabilir. Hi\u00e7 a\u011fr\u0131 yok 0(s\u0131f\u0131r) ile de\u011ferlendirilirken dayan\u0131lmaz \u015fiddette a\u011fr\u0131 10 (on) olarak nitelendirilir.<br><br><b>Kanserde A\u011fr\u0131 Tedavisi<br><\/b>D\u00fcnya sa\u011fl\u0131k \u00f6rg\u00fct\u00fc kanser a\u011fr\u0131lar\u0131 konusunda her ne kadar basamak tedavisi y\u00f6ntemini t\u00fcm d\u00fcnyaya sunsa da yeteri kadar uygulanamad\u0131\u011f\u0131 i\u00e7in a\u011fr\u0131lar kontrol alt\u0131na al\u0131namamaktad\u0131r. A\u011fr\u0131 tedavisinde temel ama\u00e7lar \u015funlard\u0131r;<br><\/p>\n<ul>\n<li>Optimal d\u00fczeyde a\u011fr\u0131 kontrol\u00fcn\u00fc sa\u011flamak<\/li>\n<li>En az yan etki yaratacak tedaviyi uygulamak<\/li>\n<li>Hastan\u0131n genel durumunu iyile\u015ftirmek<\/li>\n<li>Ya\u015fam standard\u0131n\u0131n y\u00fckseltilmesi<\/li>\n<\/ul>\n<p>Genel olarak invaziv giri\u015fim d\u00fczeyi minimum ve en etkin tedaviler planlan\u0131r. Yetersiz kald\u0131\u011f\u0131 durumlarda daha invaziv tedaviler tercih edilmektedir.<br>Kanserin do\u011frudan tedavi y\u00f6ntemleri aras\u0131nda \u015funlar bulunmaktad\u0131r;<br><\/p>\n<ul>\n<li>Cerrahi<\/li>\n<li>Kemoterapi<\/li>\n<li>Radyoterapi<\/li>\n<li>Palyatif tedavi<\/li>\n<li>Endokrin tedavi<\/li>\n<li>Radyoizotop tedavisi<\/li>\n<li>Farmakolojik tedavi<\/li>\n<li>Fizik tedavi<\/li>\n<li>Aromaterapi vs.<\/li>\n<\/ul>\n<p><b>Kanser A\u011fr\u0131lar\u0131nda Farmakolojik Tedavi<br><\/b>Kanser a\u011fr\u0131lar\u0131nda yayg\u0131n olarak kullan\u0131lan ve d\u00fcnya sa\u011fl\u0131k \u00f6rg\u00fct\u00fcn\u00fcn de \u00f6nerdi\u011fi \u201canaljezik merdiven tedavisi\u201d bulunmaktad\u0131r.<br>Basamak tedavisinde \u00f6nemli olan ilac\u0131;<br><\/p>\n<ol>\n<li>Saatinde<\/li>\n<li>A\u011f\u0131zdan<\/li>\n<\/ol>\n<p>Uygun dozlarda uygulamakt\u0131r.<br>Bu \u015fekilde bir tedavi tam olarak uyguland\u0131\u011f\u0131 takdirde a\u011fr\u0131lar\u0131n yakla\u015f\u0131k % 80\u2019i kontrol alt\u0131na al\u0131narak hasta rahatl\u0131\u011f\u0131 sa\u011flanabilmektedir.<br>Basamak tedavisinin en \u00f6nemli amac\u0131 kanser a\u011fr\u0131lar\u0131nda kullan\u0131labilirli\u011fini art\u0131rmakt\u0131r. \u0130lk basamakta nonopioid ve nonsteroid antiinflamatuar ila\u00e7 ile tedaviye ba\u015flanabilir. Daha sonra ikinci basamakta birinci basama\u011fa ek olarak kodein gibi hafif bir opioid tercih edilmelidir. A\u011fr\u0131 devam ederse morfin gibi g\u00fc\u00e7l\u00fc opioid kullan\u0131lmal\u0131d\u0131r. Tedavi uygulayanlar\u0131n en b\u00fcy\u00fck hatas\u0131 hasta hangi d\u00fczeyde a\u011fr\u0131 \u00e7ekerse \u00e7eksin tedaviye hep birinci basamaktan ba\u015flamalar\u0131d\u0131r. Fakat bu durum son derece yanl\u0131\u015ft\u0131r. Hastan\u0131n a\u011fr\u0131 skalas\u0131 g\u00f6z \u00f6n\u00fcne al\u0131narak uygun basamaktan tedaviye ba\u015flanmal\u0131d\u0131r.<br><b>Basamak Tedavisi<br><\/b>Birinci basamak: nonopioid+adjuvan<br>\u0130kinci basamak: nonopioid+adjuvan+zay\u0131f opioid<br>\u00dc\u00e7\u00fcnc\u00fc basamak: nonopioid+adjuvan+g\u00fc\u00e7l\u00fc opioid<br><b>Basamak Tedavisinin Ba\u015far\u0131 \u015eans\u0131n\u0131 Art\u0131ran Fakt\u00f6rler<br><\/b>Sistemik analjezikler uygun yoldan, do\u011fru dozda ve belirli aral\u0131klarla verilmelidir.<br>A\u011f\u0131zdan ila\u00e7 al\u0131m\u0131 kontrendike olmad\u0131\u011f\u0131 takdirde oral ilk tercih olmal\u0131d\u0131r.<br>Tedaviye nonopioid ila\u00e7larla ba\u015flanmal\u0131 fakat a\u011fr\u0131 ge\u00e7mezse adjuvan ila\u00e7lar kombin edilmelidir.<br>Hastan\u0131n a\u011fr\u0131 skalas\u0131 mutlaka g\u00f6z\u00f6n\u00fcnde bulundurulmal\u0131 ve tedavi basama\u011f\u0131 da ona uygun olarak se\u00e7ilmelidir.<br><b>Nonopiod ila\u00e7lar<br><\/b><\/p>\n<ul>\n<li>Asetaminofen<\/li>\n<li>Aspirin<\/li>\n<li>Diflusinal<\/li>\n<li>\u0130buprofen<\/li>\n<li>\u0130ndometazin<\/li>\n<li>Naproksen<\/li>\n<li>Opioid \u0130la\u00e7lar<\/li>\n<li>Morfin<\/li>\n<li>Hidromorfin<\/li>\n<li>Fentanil<\/li>\n<li>Tramadol<\/li>\n<li>Levorfanol<\/li>\n<li>Kodein<\/li>\n<li>Metadon<br><br><\/li>\n<\/ul>\n<p><b>Opioidlerin Yan Etkileri<br><\/b>Kanser a\u011fr\u0131lar\u0131 tedavisinde olmazsa olmaz ila\u00e7lardan olan opioidlerin birtak\u0131m yan etkileri mevcuttur. Bunlar;<br><\/p>\n<ul>\n<li>Bulant\u0131<\/li>\n<li>Kusma<\/li>\n<li>Diare<\/li>\n<li>Ka\u015f\u0131nt\u0131<br><br><\/li>\n<\/ul>\n<p><b>N\u00f6ropsikiyatrik bozukluklar<br><\/b><\/p>\n<ul><li>Sersemlik<\/li>\n<li>\u00dcriner retansiyon<\/li>\n<li>Konf\u00fczyon<\/li>\n<li>Pupil a\u015f\u0131r\u0131 k\u00fc\u00e7\u00fclmesi<\/li>\n<li>Miyoklonik \u00e7ekilmeler olmaktad\u0131r.<br><br><\/li>\n<\/ul>\n<p><b>Kanser Tedavisinde Giri\u015fimsel Analjezi Y\u00f6ntemleri<br><\/b>D\u00fcnya sa\u011fl\u0131k \u00f6rg\u00fct\u00fcn\u00fcn belirledi\u011fi basamak tedavisinde kullan\u0131lan analjezik ve opioid ila\u00e7lar baz\u0131 durumlarda etkisiz kalabilmektedir. Hastal\u0131k ilerledik\u00e7e a\u011fr\u0131 e\u015fi\u011fi de y\u00fckselece\u011fi i\u00e7in en ba\u015fta spinal opioid uygulamalar\u0131 ve sinir bloklar\u0131 uygulamalar\u0131 olmak \u00fczere giri\u015fimsel analjezi y\u00f6ntemleri denenebilir.<br>Basamak tedavisinden fayda sa\u011flayamayan hastalar, yan etkiler nedeniyle ila\u00e7 kullanamayan hastalar, y\u00fcksek a\u011fr\u0131 skoruna sahip olan hastalar, herhangi bir basamak tedavisine dahil olmak istemeyen hastalar \u00fczerinde giri\u015fimsel tedavi y\u00f6ntemleri kullan\u0131lmaktad\u0131r.<br><br><b>Kontrendikasyonlar\u0131 ise \u015fu \u015fekildedir:<br><\/b><\/p>\n<ul>\n<li>Kanama bozukluklar\u0131<\/li>\n<li>Enfeksiyon<\/li>\n<li>Hastan\u0131n reddi<\/li>\n<li>Hastan\u0131n tedaviyi kar\u015f\u0131layabilecek iyilikte olmamas\u0131<\/li><li>Girisimden kaynaklanan kontrendikasyonlar.<\/li><\/ul>\n<p><b>Giri\u015fimsel Analjezik Teknikleri<\/b><br><\/p>\n<ul style=\"\">\n<li style=\"\">Sinir blokajlar\u0131<\/li>\n<li style=\"\">Radyofrekans termokoag\u00fclasyon y\u00f6ntemleri<\/li>\n<li style=\"\">Epidural,intratekal, intraventrikuler opioid<\/li>\n<li style=\"\">Hipofize alkol ve gliserol tedavisi<\/li>\n<li style=\"\">Spinal kord stim\u00fclasyonu<\/li>\n<\/ul>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-988d742 elementor-align-center elementor-widget elementor-widget-button\" data-id=\"988d742\" data-element_type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-lg\" href=\"http:\/\/serdarcatav.com\/iletisim\/\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-text\">Randevu Olu\u015ftur<\/span>\n\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Kanser A\u011fr\u0131lar\u0131 Anasayfa Hastal\u0131klar Kanser A\u011fr\u0131lar\u0131 Kanser A\u011fr\u0131lar\u0131 Her kanser hastas\u0131 ya\u015fad\u0131\u011f\u0131 a\u011fr\u0131y\u0131 farkl\u0131 derecelerde tarifler. Ger\u00e7ekten de ya\u015fan\u0131lan a\u011fr\u0131n\u0131n boyutu altta yatan kanser \u00e7e\u015fidine ve v\u00fccudun direncine ba\u011fl\u0131 olarak de\u011fi\u015fkenlik g\u00f6stermektedir.Kanser A\u011fr\u0131s\u0131n\u0131n Temelde 3 Sebebi Vard\u0131r; % 75 ihtimalle kansere yol a\u00e7an t\u00fcm\u00f6r\u00fcn invazyonuna ba\u011fl\u0131 a\u011fr\u0131lar % 20 oranla kanser tedavisinde radyoterapi ve kemoterapi [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":610,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"footnotes":"","_joinchat":[]},"_links":{"self":[{"href":"https:\/\/serdarcatav.com\/ru\/wp-json\/wp\/v2\/pages\/639"}],"collection":[{"href":"https:\/\/serdarcatav.com\/ru\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/serdarcatav.com\/ru\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/serdarcatav.com\/ru\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/serdarcatav.com\/ru\/wp-json\/wp\/v2\/comments?post=639"}],"version-history":[{"count":4,"href":"https:\/\/serdarcatav.com\/ru\/wp-json\/wp\/v2\/pages\/639\/revisions"}],"predecessor-version":[{"id":643,"href":"https:\/\/serdarcatav.com\/ru\/wp-json\/wp\/v2\/pages\/639\/revisions\/643"}],"up":[{"embeddable":true,"href":"https:\/\/serdarcatav.com\/ru\/wp-json\/wp\/v2\/pages\/610"}],"wp:attachment":[{"href":"https:\/\/serdarcatav.com\/ru\/wp-json\/wp\/v2\/media?parent=639"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}